Splenectomy Impact and Outcome Among Patients With Sickle Cell Disease: A Cross‐Sectional Study
Open Access
- 7 July 2026
- journal article
- Published by Wiley in Health Science Reports
- Vol. 9 (7) , e72778
Abstract
Background: It is common to perform a splenectomy for patients with sickle cell disease (SCD); however, our understanding of its impact on long‐term clinical outcomes remains incomplete. Objectives: To evaluate the clinical outcomes of splenectomy in SCD patients and to assess perioperative physician practices. Methods: This is a retrospective cross‐sectional study that involved 245 adult Saudi patients with SCD, categorized into two groups: 40 patients who underwent splenectomy and 205 who did not. Data were gathered by structured interviews and electronic health records, including sociodemographic information, features of SCD, surgical procedures, and post‐splenectomy outcomes. Results: The splenectomy group exhibited an increased frequency of acute chest syndrome (40% vs. 8.3%) and annual hospital admissions (8.7 vs. 3.35) due to pain crises before splenectomy. Following splenectomy, they demonstrated a notable decrease in hospital admissions and the need for blood transfusions (92.5% vs. 97.1%, 82.5% vs. 84.9%, respectively). Nevertheless, they exhibited a greater prevalence of stroke, venous thrombosis, and acute chest syndrome compared to the non‐splenectomy group (15% vs. 2.4%, 12.5% vs. 2.9%, and 45% vs. 8.3%). Patients aged ≤ 33 years ( p = 0.03) and those with comorbidities ( p = 0.02) demonstrated a significant response to splenectomy. Conclusion: Splenectomy in SCD patients may result in reduced hospital admissions and blood transfusion needs. Yet, it may elevate the risk of thromboembolic events and acute chest syndrome. Optimizing outcomes require careful patient selection and perioperative management.Keywords
This publication has 23 references indexed in Scilit:
- Splenectomy in sickle cell disease: do benefits outweigh risks?Haematologica, 2022
- Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income settingHaematologica, 2022
- Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSAJournal of Taibah University Medical Sciences, 2022
- Hydroxyurea usage awareness among patients with sickle‐cell disease in Saudi ArabiaHealth Science Reports, 2021
- Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC)PLOS ONE, 2020
- Fetal haemoglobin induction in sickle cell diseaseBritish Journal of Haematology, 2017
- Splenectomy in Patients with Sickle Cell Disease in TabukOpen Access Macedonian Journal of Medical Sciences, 2016
- Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab‐Indian haplotype is not benignBritish Journal of Haematology, 2013
- Splenic Complications of Sickle Cell Anemia and the Role of SplenectomyISRN Hematology, 2011
- Acute chest syndrome: sickle cell diseaseEuropean Journal of Haematology, 2011